UNSPSC 51162652: Sulfogaiacol

This classification denotes an antitussive agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 713AJ00NPG. European Medicines Agency schedules Sulfogaiacol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10740MIG.

UNSPSC 51162652 Sulfogaiacol is a Commodity code that covers pharmaceutical and chemical products used in state and local health and emergency response contexts. Recent solicitations show state and local governments purchasing naloxone (opioid antagonist) and drug deactivation systems for community health initiatives, as well as generic multi-source pharmaceuticals and over-the-counter products distributed through cooperative purchasing networks. The code reflects actual procurement of pharmaceutical inventory rather than the narrow chemical compound its nominal name suggests; issuing bodies include county health departments and state-administered cooperative purchasing alliances that serve multiple participating jurisdictions.

Seminole County, Florida solicited naloxone and safe drug deactivation systems via IFB 60459723LAS (due July 26, 2023), seeking 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries to its Community Health Building in Sanford. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local government facilities, including Oregon, with awarded vendors effective July 1, 2026 and contract terms of two years for new responders. Geographic activity centers on Florida and the Upper Midwest, with MMCAP's multi-state cooperative purchasing model extending reach across participating jurisdictions beyond Minnesota.